Do anxiety and depression levels affect the inflammation response in patients hospitalized for COVID-19

Creative Commons License

Kahve A. C. , Kaya H., OKUYUCU M., Goka E., BARUN S., Hacimusalar Y.

Psychiatry Investigation, vol.18, no.6, pp.505-512, 2021 (Peer-Reviewed Journal) identifier identifier

  • Publication Type: Article / Article
  • Volume: 18 Issue: 6
  • Publication Date: 2021
  • Doi Number: 10.30773/pi.2021.0029
  • Journal Name: Psychiatry Investigation
  • Journal Indexes: Science Citation Index Expanded, Social Sciences Citation Index, Scopus, EMBASE
  • Page Numbers: pp.505-512


© 2021 Korean Neuropsychiatric Association.Objective The whole world is still struggling with the COVID-19 pandemic. Inflammation response, thought to be associated with severe illness and death, is an important research topic in COVID-19. Inflammation is also an essential condition explored in psychiatric illnesses. Our knowledge about the relationship between the inflammation response and psychiatric comorbidities in patients with CO-VID-19 is very limited. In this study, the relationship between anxiety and depression levels and inflammation response of patients with COVID-19 hospitalized in the hospital was examined. Methods 175 patients were included in the study. Sociodemographic Data Form, Beck Depression Inventory and Beck Anxiety Inventory were applied to the patients. To evaluate the inflammation responses, blood sedimentation rate, C-reactive protein (CRP), procalci-tonin, ferritin, neutrophil/lymphocyte ratio (NLR), and IL-6 levels were examined. Results In our study, no relationship was found between anxiety and depression levels and inflammatory responses in patients hospitalized with a diagnosis of COVID-19. Anxiety and depression levels of women were higher than men, and NLR, ferritin, IL-6 levels were found to be lower than men. Anxiety levels increase with age. There is a positive correlation between NLR and ferritin levels and duration of hospitalization. Conclusion Our study examining the relationship of psychiatric comorbidities with the inflammation response and our increasing literature knowledge, together with studies evaluating the mental effects of COVID-19, suggest that determining the relationship between inflammation responses and psychiatric comorbidities in COVID-19, whose pathophysiology has not been clarified yet, maybe an es-sential step in interventions on the course of the disease.